Contract manufacturer Spartronics names new CEO

Executive Change
Spartronics today said it appointed Jeffrey Schlarbaum as CEO effective immediately. Williamsport, Pennsylvania-based Spartronics is a contract manufacturer of complex electronic and electromechanical devices for medical devices and life sciences applications, among other industries. “Jeff has a well-established track record of leadership in the electromechanical and electronics sector, and he is the right leader for our company for its next phase of dynamic growth,” Spartronics Executive Chair Todd Bradley said in a news release. Schlarbaum was previously president and CEO of IEC Electronics Corp., an electronic contract manufacturing services company. Gross profit margins more than doubled during his time at IEC, Spartronics said, and the company posted a 24% compound annual growth rate in sales over six years. Schlarbaum led the sale of IEC to global electronics manufacturing service business Creation Technologies in October 2021. Before that, Schlarbaum was COO of privately-held laser and optics technology company Lasermax. He has also held executive positions at electronic manufacturing service companies Plexus Corp. (Nasdaq:PLXS) and Micron Custom Manufacturing. “I have long admired Spartronics for its innovation, quality and outstanding customer service and I am excited about the opportunity to help build upon that reputation,” Schlarbaum said in the news release. “There is growing need for business partners who bring both industry-specific expertise and flexibility, and I am confident that Spartronics has the talent and capabilities to seize this opportunity to drive growth.” More C-suite changes: The biggest medtech personnel moves in 2022
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Indications
-
Targets
-
Drugs
-
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.